TXO Partners LP Q1 2026 Earnings Deep Loss Per Unit Fails to Deter Investors Stock Gains 393 Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline SMPL Q1 2026 Earnings EPS Surges Past Estimates with 118 Surprise SB Q4 2025 Earnings Slight EPS Miss Amid Dry Bulk Market Volatility Shift4 Payments FOUR Q1 2026 Earnings Modest EPS Miss Amid Steady Operating Performance SGA Q1 2026 Earnings Net Loss Reported as Stock Declines 52